We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
AXT Inc
AXTI
$5.11B
| $1.52M | 0.01% |
227,226
+107,340
| +90% | +$844K |
|
577
Coca-Cola Consolidated
COKE
$12.6B
| $1.52M | 0.01% |
36,950
-1,000
| -3% | -$49.2K |
|
578
Performance Food Group
PFGC
$16.4B
| $1.51M | 0.01% |
35,277
+17,954
| +104% | +$887K |
|
579
Photronics
PLAB
$1.98B
| $1.51M | 0.01% |
103,124
-28,845
| -22% | -$567K |
|
580
AvalonBay Communities
AVB
$26.3B
| $1.48M | 0.01% |
8,053
+1,018
| +14% | +$205K |
|
|
WCC
581
WESCO International
WCC
$17.7B
| $1.48M | 0.01% |
12,363
-9,459
| -43% | -$1.18M |
|
|
EHAB
582
DELISTED
Enhabit
EHAB
| $1.46M | 0.01% |
+104,007
| New | +$1.69M |
|
583
Genpact
G
$5.7B
| $1.46M | 0.01% |
33,336
-2,025
| -6% | -$93.1K |
|
|
ESTE
584
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.46M | 0.01% |
118,438
| – | – |
|
585
OneMain Financial
OMF
$7.49B
| $1.46M | 0.01% |
49,284
-318,789
| -87% | -$11.7M |
|
586
Oppenheimer Holdings
OPY
$1.23B
| $1.45M | 0.01% |
46,864
-8,772
| -16% | -$307K |
|
587
Pinnacle West Capital
PNW
$12.2B
| $1.45M | 0.01% |
+22,430
| New | +$1.65M |
|
588
ALX Oncology
ALXO
$272M
| $1.45M | 0.01% |
151,112
+52,148
| +53% | +$608K |
|
|
UMPQ
589
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.44M | 0.01% |
84,228
-6,000
| -7% | -$107K |
|
590
Thryv Holdings
THRY
$94.7M
| $1.44M | 0.01% |
+62,925
| New | +$1.57M |
|
591
Organogenesis Holdings
ORGO
$232M
| $1.42M | 0.01% |
438,903
-7,206
| -2% | -$32.6K |
|
592
Illumina
ILMN
$28.9B
| $1.42M | 0.01% |
7,644
-73
| -0.9% | -$14.4K |
|
|
CCF
593
DELISTED
Chase Corporation
CCF
| $1.41M | 0.01% |
16,840
+3,541
| +27% | +$313K |
|
594
Radiant Logistics
RLGT
$408M
| $1.4M | 0.01% |
246,562
-1,790
| -0.7% | -$12.6K |
|
595
NMI Holdings
NMIH
$3.4B
| $1.4M | 0.01% |
68,510
-2,400
| -3% | -$47.7K |
|
596
Boeing
BA
$182B
| $1.4M | 0.01% |
11,518
+3,464
| +43% | +$531K |
|
597
TriNet
TNET
$3.16B
| $1.39M | 0.01% |
19,502
+3,504
| +22% | +$285K |
|
598
Dave & Buster's
PLAY
$374M
| $1.38M | 0.01% |
44,355
+10,579
| +31% | +$395K |
|
599
Huntington Bancshares
HBAN
$36.1B
| $1.38M | 0.01% |
104,358
-6,860
| -6% | -$91.7K |
|
600
L3Harris
LHX
$53.7B
| $1.37M | 0.01% |
6,583
+4,865
| +283% | +$1.12M |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.